Our website uses cookies to distinguish you from other users of our website to provide you with the most relevant experience by remembering your preferences and repeat visits. By clicking on ‘Accept’ you consent to our cookie policy. However, you may visit ‘Cookie Settings’ to provide a controlled consent.

Accept

News

Archive

Finally, Graphene electronic devices available for all Ventyx Biosciences reports clinical data for its NLRP3 inhibitor portfolio and provides pipeline updates at virtual investor event NorthSea Therapeutics initiates Phase 2A trial of Orziloben (NST-6179) in Intestinal Failure-Associated Liver Disease (IFALD) Resolve Therapeutics announces publication of Lupus clinical trial results biomodal delivers the 6-base genome with a powerful new multiomic solution, duet evoC InvestEU in Belgium: EIB venture debt for bone therapy innovator Novadip
Back To News
Our CMO talks solutions and projects
January 31, 2018

Our CMO talks solutions and projects

Aashu Virmani, Fuzzy Logix’ CMO was interviewed recently by independent analyst and industry expert, Ron Powell. He discusses how machine learning applies to anti-money laundering using decision trees, regression and neural nets, explains indexed data management, and gives a glimpse of 2018’s exciting new projects. Listen to the podcast.

The post Our CMO talks solutions and projects appeared first on Fuzzy Logix.

Cookie Policy Privacy Policy